期刊文献+

唯BH3域蛋白在肿瘤治疗中的研究进展

Research progress of BH3-only proteins in the treatment of cancers
下载PDF
导出
摘要 唯BH3域蛋白作为Bcl-2蛋白家族的一大亚类,通过抑制Bcl-2抗凋亡蛋白和(或)激活Bcl-2促凋亡蛋白,在调节细胞凋亡的过程中起着极其重要的作用。许多癌症中编码唯BH3域蛋白的基因发生严重突变,而且在小鼠中敲除这些基因后可诱导肿瘤的发生,这提示唯BH3域蛋白可作为肿瘤抑制剂。唯BH3域模拟物正发展为新型小分子靶向抗癌药物,这可能有助于为肿瘤设计更好的治疗策略。 As part of the Bcl-2 proteins family, BH3-only proteins play an extremely important role in the regulation of apoptosis by inhibiting the activity of Bcl-2 anti-apoptotic proteins and(or) activating Bcl-2 pro-apoptotic proteins. Mutations crippling genes encoding BH3-only proteins have been detected in a range of human cancers and these genes knocked out accelerate cancers in mice, which provided evidence that BH3-only proteins can serve as tumour suppressors. BH3 mimetic are being developed for the new molecularly targeted anti-cancer drugs, which may be helpful in designing better therapeutic strategy for treating cancers.
作者 姚锴 戴德
机构地区 广东医学院
出处 《海南医学》 CAS 2016年第12期1993-1995,共3页 Hainan Medical Journal
关键词 唯BH3域蛋白 细胞凋亡 肿瘤治疗 BH3-only proteins Cell apoptosis Cancer therapy
  • 相关文献

参考文献24

  • 1Beroukhim Rameen,Mermel Craig H,Porter Dale,Wei Guo,Raychaudhuri Soumya,Donovan Jerry,Barretina Jordi,Boehm Jesse S,Dobson Jennifer,Urashima Mitsuyoshi,Mc Henry Kevin T,Pinchback Reid M,Ligon Azra H,Cho Yoon-Jae,Haery Leila,Greulich Heidi.The landscape of somatic copy-number alteration across human cancers. Nature . 2010
  • 2Mühleisen A,Giaisi M,K?hler R,et al.Tax contributes apoptosis resistance to HTLV-1 infected T cells via suppression of Bid and Bim expression. Cell Death Dis . 2014
  • 3Abulwerdi F,Liao C,Liu M,et al.A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo. Molecular Cancer Therapeutics . 2014
  • 4Zhichao Zhang,Ting Song,Tiantai Zhang.A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1. International Journal of Cancer . 2011
  • 5Liu Glenn,Kelly W Kevin,Wilding George,Leopold Lance,Brill Kimberli,Somer Bradley.An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research . 2009
  • 6Trudel Suzanne,Li Zhi Hua,Rauw Jennifer,Tiedemann Rodger E,Wen Xiao Yan,Stewart A Keith.Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma. Blood . 2007
  • 7Nichola Cruickshanks,Yong Tang,Laurence Booth.Lapatinib and Obatoclax Kill Breast Cancer Cells through Reactive Oxygen Species-Dependent Endoplasmic Reticulum Stress. Molecular Pharmacology . 2012
  • 8Gandhi Leena,Camidge D Ross,Ribeiro de Oliveira Moacyr,Bonomi Philip,Gandara David,Khaira Divis,Hann Christine L,McKeegan Evelyn M,Litvinovich Elizabeth,Hemken Philip M,Dive Caroline,Enschede Sari H,Nolan Cathy,Chiu Yi-Lin,Busman Todd,Xiong.Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2011
  • 9Fennell D A,Chacko A,Mutti L.BCL-2 family regulation by the 20S proteasome inhibitor bortezomib. Oncegene . 2007
  • 10闫峰,王效民,马全明,袁思波,蒋楠.Bim和细胞外调节蛋白在肝癌多药耐药细胞中的表达[J].南方医科大学学报,2014,34(12):1838-1841. 被引量:3

二级参考文献73

  • 1王其,陈孝平,张万广,张必翔.人肝癌HepG2多药耐药细胞系的部分生物学性状研究[J].中华实验外科杂志,2004,21(5):538-540. 被引量:40
  • 2赵亚宁,李强.前凋亡蛋白Bim研究进展[J].国际输血及血液学杂志,2006,29(1):33-36. 被引量:2
  • 3Adams JM, Cory S. Life-or-death decisions by the Bcl-2 pro- tein family. Trends Biochem Sei 2001; 26:61-66.
  • 4Opferman JT, Korsmeyer SJ. Apoptosis in the development and maintenance of the immune system. Nat Immunol 2003; 4:410-415.
  • 5Antignani A, Youle RJ. How do Bax and Bak lead to permea- bilization of the outer mitochondrial membrane? Curr Opin Cell Bio12006; 18:685-689.
  • 6Green DR, Kroemer G. The pathophysiology of mitochon- drial cell death. Science 2004; 305:626-629.
  • 7Kim H, Rafiuddin-Shah M, Tu HC, et al. Hierarchical regula- tion of mitochondrion-dependent apoptosis by BCL-2 sub- families. Nat Cell Bio12006: 8:1348-1358.
  • 8Willis SN, Fletcher JI, Kaufmann T, et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007; 315:856-859.
  • 9Sattler M, Liang H, Nettesheim D, et al. Structure of Bcl- xL-Bak peptide complex: recognition between regulators of apoptosis. Science 1997; 275:983-986.
  • 10Liu X, Dai S, Zhu Y, Marrack P, Kappler JW. The structure of a Bcl-xL/Bim fragment complex: implications for Bim func- tion. Immunity 2003; 19:341-352.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部